First co-registered and co-aligned IVUS-OCT Platform for Intravascular Imaging - Company Positioned for U.S. Commercial Launch in a Growing ...
Conavi Medical Corp. (“Conavi” or the “Company”) (TSXV: CNVI; OTCQB: CNVIF), a commercial-stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide ...
TORONTO, July 30, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Inc. (TSXV: CNVI) (OTCQB: CNVIF), a leader in hybrid intravascular imaging, is pleased to announce the publication of a compelling case report ...
TORONTO, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (CNVI:CA) (OTCQB: CNVIF) (“Conavi” or the “Company”), a commercial-stage medical device company focused on designing, manufacturing, ...
Hosted on MSN
Conavi Medical advances hybrid intravascular imaging platform as revenue jumps in fiscal 2025
An update from Conavi Medical ( (TSE:CNVI)) is now available. Conavi Medical reported that fiscal 2025 marked a pivotal year, highlighted by the U.S. FDA 510(k) submission of its next-generation ...
Optical coherence tomography (OCT) provides safe and improved guidance for patients undergoing percutaneous coronary intervention to treat coronary artery disease, according to results from the ...
TCT 690: Assessing the Learning Curve for Coronary Intravascular Ultrasound Use in the Cardiac Catheterisation Laboratory. Receive the the latest news, research, and presentations from major meetings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results